Leukemia, Myeloid, Chronic-Phase
Information
- Disease name
- Leukemia, Myeloid, Chronic-Phase
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00103701 | Completed | Phase 1 | BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia | November 2003 | March 2006 |
| NCT01856283 | Completed | Phase 2 | Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells | March 2013 | January 2021 |
| NCT02888964 | Completed | Phase 2 | Pioglityazone and Imatinib for CML Patients | December 2009 | February 2016 |
| NCT00048672 | Completed | Phase 2 | Therapy of Early Chronic Phase CML With Gleevec | March 2001 | August 2013 |
| NCT01725204 | Completed | Phase 2 | Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia | September 2012 | May 2016 |
| NCT03807479 | Terminated | Phase 2 | Study in Patients With Chronic Leukemia | December 11, 2018 | August 31, 2023 |
| NCT01488253 | Terminated | Phase 2 | Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants | January 2012 | October 2014 |
| NCT01827930 | Terminated | Phase 3 | Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response | July 2009 | January 1, 2017 |
| NCT02767063 | Unknown status | Phase 1/Phase 2 | Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) | July 2016 | June 2023 |
| NCT03239886 | Unknown status | N/A | Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log | December 15, 2016 | January 31, 2020 |
| NCT01650467 | Withdrawn | Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms | December 2014 | June 2017 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015466